Blood clots kill as many as 1760 people of ALL ages each year in the greater Washington DC area
Many of these lives can be saved
WASHINGTON--(BUSINESS WIRE)-- National Blood Clot Alliance:
|Date:||Saturday, March 10, 2012|
|Time:||8:00 am – 12:30 pm|
|Location:||Georgetown University Hospital, Gorman Auditorium, Washington DC 20007|
Preregister or 877-4-NOCLOT.
Craig Kessler, MD, Chief of Hematology, Georgetown University Hospital:
“People who treat their first blood clot casually, are more likely to have a second clot. An educated patient is a healthier patient.”
Jonathan Puhl, Pharm D, Clinical Pharmacist, Georgetown University Hospital:
“We don’t just give our patients medication to prevent clots, we educate them on how to reduce their risk of a clot.”
Adam Wolk, MD, Georgetown University Hospital Anticoagulation Clinic:
“Blood thinners are great at preventing clots, but they are tricky to use properly. Patients need to be highly involved in their own care.”
- Approximately 600,000 Americans develop a serious blood clot every year – and the number is going up. If you already had one clot, you are at risk the rest of your life.
- 10-30% of patients die in the first month after diagnosis.
- Nearly one in 20 Americans has an inherited tendency to develop clots.
- Do you take long trips, especially by plane? Deep vein thrombosis (DVT) and pulmonary embolism (PE) can often be prevented.
- Nearly half of serious clots are not diagnosed promptly. Many are never diagnosed.
About the National Blood Clot Alliance:
The National Blood Clot Alliance (NBCA) is a patient-led organization combining the unique perspectives of healthcare providers, individuals afflicted with clotting disorders and community leaders. Our web site is www.StopTheClot.org. NBCA programs include patient and professional education. Programs are sponsored by a grant from the Centers for Disease Control and donations. Host a forum in your area.
KEYWORDS: United States North America District of Columbia
INDUSTRY KEYWORDS: Surgery Health Cardiology Hospitals Oncology Pharmaceutical Other Health General Health